News

News Room

2025.02.27

Cross-Border Cooperation for a Promising Future: Neuboron Joins Hands with YCYW to Launch BNCT Study Program
News
Innovative Application of Lipoic Acid-Boronophenylalanine Derivatives in BNCT: Neuboron Facilitates New Research Breakthroughs

2025.02.19

174
News
2025 China BNCT: New Start & New Breakthroughs! ¹⁸F-BPA Approved for IND, BPA Initiates Phase Ib Clinical Trial

2025.01.27

225
News
Chaoshan Hecheng Hospital and Neuboron Sign Cooperation on BNCT Technology, the First of Its Kind in Eastern Guangdong

2025.01.12

184
News
Xiamen BNCT Drug-Device Combined Registered Clinical Trial Seminar & First Meeting of the Expert Committee of Xiamen Humanity Hospital International BNCT Center Successfully Held

2024.12.30

181
News
Neuboron Wins Silver Award at the 2nd "Zhongzhilu" Yangtze River Delta High-Value Patent Operation Competition 2024

2024.12.06

192
News
Neuboron: Independently Developed Integrated BNCT Drug-Device Solution Debuts at CSTRO

2024.11.19

201
News
Great News! Neuboron Wins First Prize of 2023 China Radiation Protection Society Science and Technology Award

2024.09.12

184
News
Ranking First in Patent Count: Neuboron Leads Global BNCT Technological Innovation and Patent Layout

2024.08.14

166
News
Deepening International Exchange and Cooperation: Chinese and Foreign Experts Jointly Blueprint the New Prospect of BNCT

2024.07.27

183
News
ICNCT-20 Resonates with China's Voice: Neuboron Delivers 7 Outstanding Academic Reports

2024.07.10

195
News
Neuboron and Shanghai Lingang Digital Sea Sign Strategic Cooperation Agreement

2024.07.05

470
News
Significant Milestone! First Patient Enrolled in Phase I Clinical Trial of Neuboron's BNCT Drug-Device Product

2024.05.31

1240
News
First in China! Neuboron’s BNCT Drug-Device Product Phase I Registration Clinical Trial Launched at Xiamen Humanity Hospital

2024.04.24

1627
News
Major Progress! Neuboron's Accelerator-Based BNCT Treatment System "NeuPEX Block-I" Passes Registration Inspection

2024.03.31

1710

Events

News Room

Cross-Border Cooperation for a Promising Future: Neuboron Joins Hands with YCYW to Launch BNCT Study Program

Innovative Application of Lipoic Acid-Boronophenylalanine Derivatives in BNCT: Neuboron Facilitates New Research Breakthroughs

2025 China BNCT: New Start & New Breakthroughs! ¹⁸F-BPA Approved for IND, BPA Initiates Phase Ib Clinical Trial

Chaoshan Hecheng Hospital and Neuboron Sign Cooperation on BNCT Technology, the First of Its Kind in Eastern Guangdong

Xiamen BNCT Drug-Device Combined Registered Clinical Trial Seminar & First Meeting of the Expert Committee of Xiamen Humanity Hospital International BNCT Center Successfully Held

Neuboron Wins Silver Award at the 2nd "Zhongzhilu" Yangtze River Delta High-Value Patent Operation Competition 2024

Neuboron: Independently Developed Integrated BNCT Drug-Device Solution Debuts at CSTRO

Great News! Neuboron Wins First Prize of 2023 China Radiation Protection Society Science and Technology Award

Ranking First in Patent Count: Neuboron Leads Global BNCT Technological Innovation and Patent Layout

Deepening International Exchange and Cooperation: Chinese and Foreign Experts Jointly Blueprint the New Prospect of BNCT

ICNCT-20 Resonates with China's Voice: Neuboron Delivers 7 Outstanding Academic Reports

Neuboron and Shanghai Lingang Digital Sea Sign Strategic Cooperation Agreement

Significant Milestone! First Patient Enrolled in Phase I Clinical Trial of Neuboron's BNCT Drug-Device Product

First in China! Neuboron’s BNCT Drug-Device Product Phase I Registration Clinical Trial Launched at Xiamen Humanity Hospital

Major Progress! Neuboron's Accelerator-Based BNCT Treatment System "NeuPEX Block-I" Passes Registration Inspection